TERI DUGGAN: Open Payments
NPI 1992282719 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,553 in 14 payments from 11 companies in 2025. Trend: 2023 $2,123 · 2024 $1,480 · 2025 $1,553
Food & beverage: $1,553
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $348 |
| Neurocrine BioSciences, Inc. | 2 | $147 |
| Insulet Corporation | 1 | $127 |
| ABBVIE INC. | 1 | $125 |
| Ardelyx, Inc. | 1 | $125 |
| Corcept Therapeutics | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| KYOWA KIRIN, INC. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Melinta Therapeutics, LLC | 1 | $125 |
Products named: FREESTYLE LIBRE 3, OMNIPOD, VRAYLAR, IBSRELA, Korlym, Auvelity, AIRSUPRA, Rezzayo.
Industry payments across LA — which companies pay providers there.
